A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.

导出原文传递

翻译打印收藏纠错

第一作者： Tiantian,Liu

第一单位： State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.

作者： Tiantian,Liu ^[1] ; Zhichao,Zhou ^[1] ; Xingui,Tian ^[1] ; Wenkuan,Liu ^[1] ; Duo,Xu ^[1] ; Ye,Fan ^[1] ; Jiayi,Liao ^[1] ; Shujun,Gu ^[1] ; Xiao,Li ^[2] ; Rong,Zhou ^[3]

作者单位： State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China. ^[1] State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China. Electronic address: lixiao@gird.cn. ^[2] State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China. Electronic address: zhourong@gird.cn. ^[3]

关键词 Adenovirus HAdV-3 HAdV-55 HAdV-7 Hexon Trivalent vaccine